Metabolomics Workbench : NIH Data Repository

MB Sample ID: SA220148

Local Sample ID:	ID_175
Subject ID:	SU002377
Subject Type:	Human
Subject Species:	Homo sapiens
Taxonomy ID:	9606

Select appropriate tab below to view additional metadata details:

Treatment:

Treatment ID:	TR002389
Treatment Summary:	The criteria defined on COVID-19 Treatment Guidelines (National Institute of Health, USA) and World Health Organization [21,22] were used to stratify individuals with COVID-19 into mild disease (individuals presenting various signs and symptoms without shortness of breath, dyspnea, or abnormal chest imaging), moderate disease (individuals presenting radiologically confirmed pneumonitis, hospitalization and oxygen therapy), severe disease (dyspnea, respiratory frequency ≥30 breaths/min, saturation of oxygen [SpO2] ≤ 93%, and/or lung infiltrates >50% within 24 to 48 hours, including individuals that required monitoring and treatment in Intensive Care Unit and mechanical ventilation), or fatal COVID-19.

Treatment ID:

TR002389

Treatment Summary:

The criteria defined on COVID-19 Treatment Guidelines (National Institute of Health, USA) and World Health Organization [21,22] were used to stratify individuals with COVID-19 into mild disease (individuals presenting various signs and symptoms without shortness of breath, dyspnea, or abnormal chest imaging), moderate disease (individuals presenting radiologically confirmed pneumonitis, hospitalization and oxygen therapy), severe disease (dyspnea, respiratory frequency ≥30 breaths/min, saturation of oxygen [SpO2] ≤ 93%, and/or lung infiltrates >50% within 24 to 48 hours, including individuals that required monitoring and treatment in Intensive Care Unit and mechanical ventilation), or fatal COVID-19.